|
1
|
Kodama M, Higuchi H, Ishii-Maruhama M,
Nakano M, Honda-Wakasugi Y, Maeda S and Miyawaki T: Multi-drug
therapy for epilepsy influenced bispectral index after a bolus
propofol administration without affecting propofol's
pharmacokinetics: A prospective cohort study. Sci Rep.
10:15782020.PubMed/NCBI
|
|
2
|
Sona Khan M, Trenet W, Xing N, Sibley B,
Abbas M, Al-Rashida M, Rauf K and Mandyam CD: A novel sulfonamide,
4-FS, reduces ethanol drinking and physical withdrawal associated
with ethanol dependence. Int J Mol Sci. 21:44112020.
|
|
3
|
Yoon HK, Jun K, Park SK, Ji SH, Jang YE,
Yoo S, Kim JT and Kim WH: Anesthetic agents and cardiovascular
outcomes of noncardiac surgery after coronary stent insertion. J
Clin Med. 9:4292020.
|
|
4
|
Kang Y, Saito M and Toyoda H: Molecular
and regulatory mechanisms of desensitization and resensitization of
GABAA receptors with a special reference to propofol/barbiturate.
Int J Mol Sci. 21:5632020.
|
|
5
|
Cho YJ, Nam K, Kim TK, Choi SW, Kim SJ,
Hausenloy DJ and Jeon Y: Sevoflurane, propofol and carvedilol block
myocardial protection by limb remote ischemic preconditioning. Int
J Mol Sci. 20:2692019.
|
|
6
|
Sun H and Gao D: Propofol suppresses
growth, migration and invasion of A549 cells by down-regulation of
miR-372. BMC Cancer. 18:12522018.PubMed/NCBI
|
|
7
|
Vasileiou I, Xanthos T, Koudouna E, Perrea
D, Klonaris C, Katsargyris A and Papadimitriou L: Propofol: A
review of its non-anaesthetic effects. Eur J Pharmacol. 605:1–8.
2009.PubMed/NCBI
|
|
8
|
Bode AM, Dong Z and Wang H: Cancer
prevention and control: Alarming challenges in China. Natl Sci Rev.
3:117–127. 2016.PubMed/NCBI
|
|
9
|
Xia T, Zhu Y, Mu L, Zhang ZF and Liu S:
Pulmonary diseases induced by ambient ultrafine and engineered
nanoparticles in twenty-first century. Natl Sci Rev. 3:416–429.
2016.PubMed/NCBI
|
|
10
|
Zanoaga O, Braicu C, Jurj A, Rusu A, Buiga
R and Berindan-Neagoe I: Progress in research on the role of
flavonoids in lung cancer. Int J Mol Sci. 20:42912019.
|
|
11
|
Loong HH, Kwan SS, Mok TS and Lau YM:
Therapeutic strategies in EGFR mutant non-small cell lung cancer.
Curr Treat Options Oncol. 19:582018.PubMed/NCBI
|
|
12
|
Xue J, Yang J, Luo M, Cho WC and Liu X:
MicroRNA-targeted therapeutics for lung cancer treatment. Expert
Opin Drug Discov. 12:141–157. 2017.PubMed/NCBI
|
|
13
|
Sarne V, Huter S, Braunmueller S, Rakob L,
Jacobi N, Kitzwögerer M, Wiesner C, Obrist P and Seeboeck R:
Promoter methylation of selected genes in non-small-cell lung
cancer patients and cell lines. Int J Mol Sci. 21:45952020.
|
|
14
|
Wang Q, Liu S, Zhao X, Wang Y, Tian D and
Jiang W: MiR-372-3p promotes cell growth and metastasis by
targeting FGF9 in lung squamous cell carcinoma. Cancer Med.
6:1323–1330. 2017.PubMed/NCBI
|
|
15
|
Wang X, Li W, Zhang N, Zheng X and Jing Z:
Opportunities and challenges of co-targeting epidermal growth
factor receptor and autophagy signaling in non-small cell lung
cancer. Oncol Lett. 18:499–506. 2019.PubMed/NCBI
|
|
16
|
Wang H, Peng X, Huang Y, Xiao Y, Wang Z
and Zhan L: Propofol attenuates hypoxia/reoxygenation-induced
apoptosis and autophagy in HK-2 cells by inhibiting JNK activation.
Yonsei Med J. 60:1195–1202. 2019.PubMed/NCBI
|
|
17
|
Xue Y, Han H, Wu L, Pan B, Dong B, Yin CC,
Tian Z, Liu X, Yang Y, Zhang H, et al: iASPP facilitates tumor
growth by promoting mTOR-dependent autophagy in human
non-small-cell lung cancer. Cell Death Dis. 8:e31502017.PubMed/NCBI
|
|
18
|
Liu Z, Chen P, Gao H, Gu Y, Yang J, Peng
H, Xu X, Wang H, Yang M, Liu X, et al: Ubiquitylation of autophagy
receptor optineurin by HACE1 activates selective autophagy for
tumor suppression. Cancer Cell. 26:106–120. 2014.PubMed/NCBI
|
|
19
|
Liao SX, Sun PP, Gu YH, Rao XM, Zhang LY
and Ou-Yang Y: Autophagy and pulmonary disease. Ther Adv Respir
Dis. 13:17534666198905382019.PubMed/NCBI
|
|
20
|
Xu YB, Du QH, Zhang MY, Yun P and He CY:
Propofol suppresses proliferation, invasion and angiogenesis by
down-regulating ERK-VEGF/MMP-9 signaling in Eca-109 esophageal
squamous cell carcinoma cells. Eur Rev Med Pharmacol Sci.
17:2486–2494. 2013.PubMed/NCBI
|
|
21
|
Xu X, Li C, Gao X, Xia K, Guo H, Li Y, Hao
Z, Zhang L, Gao D, Xu C, et al: Excessive UBE3A dosage impairs
retinoic acid signaling and synaptic plasticity in autism spectrum
disorders. Cell Res. 28:48–68. 2018.PubMed/NCBI
|
|
22
|
Li C, Han T, Guo R, Chen P, Peng C, Prag G
and Hu R: An integrative synthetic biology approach to
interrogating cellular ubiquitin and ufm signaling. Int J Mol Sci.
21:42312020.
|
|
23
|
Longchamps RJ, Castellani CA, Yang SY,
Newcomb CE, Sumpter JA, Lane J, Grove ML, Guallar E, Pankratz N,
Taylor KD, et al: Evaluation of mitochondrial DNA copy number
estimation techniques. PLoS One. 15:e02281662020.PubMed/NCBI
|
|
24
|
Yu Z, Li Y, Han T and Liu Z: Demethylation
of the HACE1 gene promoter inhibits the proliferation of human
liver cancer cells. Oncol Lett. 17:4361–4368. 2019.PubMed/NCBI
|
|
25
|
Li H, Liang Z, Yang J, Wang D, Wang H, Zhu
M, Geng B and Xu EY: DAZL is a master translational regulator of
murine spermatogenesis. Natl Sci Rev. 6:455–468. 2019.PubMed/NCBI
|
|
26
|
Li C, Lu W, Yang L, Li Z, Zhou X, Guo R,
Wang J, Wu Z, Dong Z, Ning G, et al: MKRN3 regulates the epigenetic
switch of mammalian puberty via ubiquitination of MBD3. Natl Sci
Rev. 7:671–685. 2020.
|
|
27
|
Hsing CH, Lin MC, Choi PC, Huang WC, Kai
JI, Tsai CC, Cheng YL, Hsieh CY, Wang CY, Chang YP, et al:
Anesthetic propofol reduces endotoxic inflammation by inhibiting
reactive oxygen species-regulated Akt/IKKβ/NF-κB signaling. PLoS
One. 6:e175982011.PubMed/NCBI
|
|
28
|
Cui D, Wang L, Qi A, Zhou Q, Zhang X and
Jiang W: Propofol prevents autophagic cell death following oxygen
and glucose deprivation in PC12 cells and cerebral
ischemia-reperfusion injury in rats. PLoS One.
7:e353242012.PubMed/NCBI
|
|
29
|
Zhang L, Wang N, Zhou S, Ye W, Jing G and
Zhang M: Propofol induces proliferation and invasion of gallbladder
cancer cells through activation of Nrf2. J Exp Clin Cancer Res.
31:662012.PubMed/NCBI
|
|
30
|
Du Q, Liu J, Zhang X, Zhang X, Zhu H, Wei
M and Wang S: Propofol inhibits proliferation, migration, and
invasion but promotes apoptosis by regulation of Sox4 in
endometrial cancer cells. Braz J Med Biol Res.
51:e68032018.PubMed/NCBI
|
|
31
|
Liu WZ and Liu N: Propofol inhibits lung
cancer A549 cell growth and epithelial-mesenchymal transition
process by upregulation of MicroRNA-1284. Oncol Res. 27:1–8.
2018.PubMed/NCBI
|
|
32
|
Xu X, Tao Y, Gao X, Zhang L, Li X, Zou W,
Ruan K, Wang F, Xu GL and Hu R: A CRISPR-based approach for
targeted DNA demethylation. Cell Discov. 2:160092016.PubMed/NCBI
|
|
33
|
Brown SE, Suderman MJ, Hallett M and Szyf
M: DNA demethylation induced by the methyl-CpG-binding domain
protein MBD3. Gene. 420:99–106. 2008.PubMed/NCBI
|
|
34
|
Peng L, Li Y, Xi Y, Li W, Li J, Lv R,
Zhang L, Zou Q, Dong S, Luo H, et al: MBD3L2 promotes Tet2
enzymatic activity for mediating 5-methylcytosine oxidation. J Cell
Sci. 129:1059–1071. 2016.PubMed/NCBI
|
|
35
|
Brown SE and Szyf M: Epigenetic
programming of the rRNA promoter by MBD3. Mol Cell Biol.
27:4938–4952. 2007.PubMed/NCBI
|
|
36
|
Lee CW, Wilfling F, Ronchi P, Allegretti
M, Mosalaganti S, Jentsch S, Beck M and Pfander B: Selective
autophagy degrades nuclear pore complexes. Nat Cell Biol.
22:159–166. 2020.PubMed/NCBI
|
|
37
|
Yamasaki A, Alam JM, Noshiro D, Hirata E,
Fujioka Y, Suzuki K, Ohsumi Y and Noda NN: Liquidity is a critical
determinant for selective autophagy of protein condensates. Mol
Cell. 77:1163–1175.e9. 2020.PubMed/NCBI
|
|
38
|
Zhao ZQ, Yu ZY, Li J and Ouyang XN:
Gefitinib induces lung cancer cell autophagy and apoptosis via
blockade of the PI3K/AKT/mTOR pathway. Oncol Lett. 12:63–68.
2016.PubMed/NCBI
|
|
39
|
Ren S, Ding C and Sun Y: Morphology
remodeling and selective autophagy of intracellular organelles
during viral infections. Int J Mol Sci. 21:36892020.
|
